Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

• Status: Completed
• Trial end date: 2014-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the effects of vilazodone, paroxetine and placebo on sexual function in sexually active healthy adults.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Forest Laboratories
• Treatments: Paroxetine; Vilazodone Hydrochloride

Criteria

Inclusion Criteria:

• Healthy male or female, aged 18 through 45 years, inclusive

• Currently sexually active

• If female, non pregnant and agree to use acceptable for of contraception during

• If male, be sterile or have partner use contraception.

Exclusion Criteria:

• Have sexual dysfunction

• Have history of diagnosis or treatment of any disorder related to sexual functioning.

• Clinically significant disease state, in the opinion of the examining physician, in any body system

• History of alcohol or other substance abuse or dependence within the previous 5 years